Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil in Chronic Rhinosinusitis
NCT02454608Terminated
- Start
- May 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of verapamil in chronic rhinosinusitis with nasal polyps (CRSwNP) (3 arms). Primary endpoints: Sinonasal Outcomes Test-22 at 56 weeks and Visual Analogue Scale at 56 weeks. Started May 2015; status: terminated.
02
Drugs
verapamil
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT02454608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02454608.